UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Amendment No. 1 to
||QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934|
||For the quarterly period ended June 30, 2012|
||TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934|
||For the transition period from to _________________|
Commission File Number 001-33216
OCULUS INNOVATIVE SCIENCES, INC.
(Exact name of registrant as specified in
(State or other jurisdiction of
incorporation or organization)
1129 North McDowell Blvd.
Petaluma, CA 94954
(Address of principal executive offices)
Registrant’s telephone number, including
by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes þ
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions
of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2
of the Exchange Act.
|Large accelerated filer
||Smaller reporting company|
||(Do not check if a smaller reporting company) o
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o
As of August 28, 2012, the
number of shares outstanding of the registrant’s common stock, $0.0001 par value, was 32,557,634.
The sole purpose of this Amendment No. 1 to
Oculus Innovative Sciences, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012 (the
“Form 10-Q”) is to furnish the interactive data files as required by Rule 405 of Regulation S-T. Exhibit 101 to
this Amendment No. 1 provides the following materials from the Form 10-Q formatted in XBRL (eXtensible Business
Reporting Language) with detailed footnote tagging: (i) condensed consolidated balance sheets, (ii) condensed consolidated
statements of operations, (iii) condensed consolidated statements of cash flows, and (iv) the notes to the condensed
consolidated financial statements. This Amendment is an exhibit-only filing.
Except as set forth above, no other changes have been made to
the Form 10-Q, and this Amendment No. 1 does not amend, update or change any other items or disclosure found in the Form 10-Q.
Further, this Amendment No. 1 does not reflect subsequent events occurring after the original filing date of the Form 10-Q or modify
or update in any way disclosures made in the Form 10-Q.
In addition, as required by Rule 12b-15 under the Securities
Exchange Act of 1934, as amended, new certifications by our principal executive officer and principal financial officer are filed
herewith as exhibits to this Amendment No. 1.
Item 6. Exhibits
||Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.|
||Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.|
||Certification of Officers pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.|
||XBRL Instance Document|
||XBRL Schema Document|
||XBRL Calculation Linkbase Document|
||XBRL Definition Linkbase Document|
||XBRL Label Linkbase Document|
||XBRL Presentation Linkbase Document|
* Filed herewith.
# Pursuant to Rule 406T of Regulation S-T, the
interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for
purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
||OCULUS INNOVATIVE SCIENCES, INC.|
|Date: August 31, 2012
||/s/ Hojabr Alimi|
||Chairman of the Board of Directors and Chief Executive Officer|
|| (Principal Executive Officer)|
|Date: August 31, 2012
||/s/ Robert Miller|
||Chief Financial Officer|
||(Principal Financial Officer and Principal Accounting Officer)|